CD4 and neoplasm: Notably, elevated ENO1 expression in the tumor and aging groups significantly increased CD4-positive, α-β regulatory T cell differentiation within Type 2 T helper cells, enhancing PD-L1 expression and the PD-1 checkpoint pathway activity (Figure 7G).